Page last updated: 2024-10-22

alosetron and Dilatation, Pathologic

alosetron has been researched along with Dilatation, Pathologic in 1 studies

alosetron : A pyrido[4,3-b]indole compound having a 5-methyl-1H-imidazol-4-ylmethyl group at the 2-position.

Dilatation, Pathologic: The condition of an anatomical structure's being dilated beyond normal dimensions.

Research Excerpts

ExcerptRelevanceReference
"alosetron treated rats failed to demonstrate any alteration in the VMR."1.33Effects of the 5-HT3 receptor antagonist, alosetron, in a rat model of somatic and visceral hyperalgesia. ( McLean, PG; Miranda, A; Peles, S; Sengupta, JN, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miranda, A1
Peles, S1
McLean, PG1
Sengupta, JN1

Other Studies

1 other study available for alosetron and Dilatation, Pathologic

ArticleYear
Effects of the 5-HT3 receptor antagonist, alosetron, in a rat model of somatic and visceral hyperalgesia.
    Pain, 2006, Dec-15, Volume: 126, Issue:1-3

    Topics: Absorption; Animals; Carbolines; Colon; Dilatation, Pathologic; Electromyography; Gastrointestinal M

2006